Clinical Trial Update: Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of a botulinum toxin type A topical gel for primary axillary hyperhidrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axillary Hyperhidrosis
• Hyperhidrosis

Drugs mentioned

• Botulinum toxin type A topical gel (botulinum toxin type A topical gel)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED